HOUSTON -- Prostate cancer that spreads to the bone triggers the destruction of bone tissue that, in turn, thwarts the effectiveness of immune checkpoint inhibitors by blocking the development of T ...

The overall and failure-free survival benefit of adding prostate radiation therapy to standard of care for metastatic prostate cancer declines with increasing number of bone metastases, a study found.

Prostate cancer that spreads to the bone triggers the destruction of bone tissue that, in turn, thwarts the effectiveness of immune checkpoint inhibitors by blocking the development of T cells that ...

A study suggests a new approach, or, possibly two new approaches against prostate cancer bone metastases: While targeted therapies and anti-cancer immunotherapies have not been especially successful ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Prostate cancer treatment can be detrimental to bone and muscle health, but an exercise regimen and healthy eating habits can help. Androgen deprivation therapy (ADT), also known as hormone therapy, ...

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

Researchers from MD Anderson in Texas have uncovered new clues as to why immunotherapy may fail in many men with prostate cancer. Immunotherapy drugs called immune checkpoint inhibitors have ...

Dr Bock, under the mentorship of Distinguished Professor Dietmar Hutmacher, from QUT Centre for Biomedical Technologies, has focused her research on bone metastases from breast and prostate cancers.

CORRECTED July 30, 2021 // There may be a notable survival benefit for men with advanced prostate cancer and bone metastases when they are prescribed bone-protecting drugs after progressing to ...

Anti-androgen therapy is commonly used to treat patients with advanced prostate cancer at stages where the disease has spread to the bones. However, new research has found that anti-androgen treatment ...